Literature DB >> 20040942

The concept of personal drugs in the undergraduate pharmacology practical curriculum.

Gurudas Khilnani1.   

Abstract

Entities:  

Year:  2008        PMID: 20040942      PMCID: PMC2792601          DOI: 10.4103/0253-7613.42308

Source DB:  PubMed          Journal:  Indian J Pharmacol        ISSN: 0253-7613            Impact factor:   1.200


× No keyword cloud information.
I have read the thought provoking research letter by Dr Parmar and Jadav on The concept of personal drugs in the undergraduate pharmacology practical curriculum.[1] I have the following comments to share with the readership of the IJP. The concept of P-drug for the undergraduate practical curriculum is a good instrument to promote the practice of rational therapeutics with the objective to promote use of cost effective, safe and suitable medicines. However, the concept needs to be utilized in its right perspective so that it does not leave enough to question its utility. In selecting a P-drug for acute amoebic dysentery so far as the drug group is concerned, nitroimidazoles may be the choice. However, choosing a drug among this group will require utilization of certain criteria. Therefore, using the criteria of efficacy, safety, suitability and affordability [Table 1], one may conclude that tinidazole is a better choice to be a P-drug (along with a luminal amoebicide-vide infra). This is because of its suitability i.e., once or twice daily intake) and comparable cost of a course of treatment (3 days for tinidazole v/s 7-10 days of metronidazole). The authors have ignored the suitability factor. It is one of the important criteria for selecting a P-drug. It not only includes patient-related conditions, which preclude the use of selected drug, but also the convenience of dosage form and dosage schedule.[2] Adherence to treatment is improved by creating a good doctor-patient relationship, giving necessary drug related information to the patient and most importantly, prescribing a few drugs with a simple dosage schedule (one or two times a day).[2]
Table 1

Comparison of nitroimidazoles in acute amoebic dysentery[4]

DrugDose and durationAverage cost (Rs.) per courseEfficacy/suitability
Metronidazole400-800 mg 3 times a ady for 7-10 days27-00Equal/suitable
Tinidazole1 G/day for 3 days21-25Equal/more suitable
Secnidazole2 G single dose35-00Equal/suitable but costly
Comparison of nitroimidazoles in acute amoebic dysentery[4] It is difficult to agree with the authors' proposition of ignoring the advice of clinical teachers in selecting P-drug. Medical teachers have gained expertise from long standing practice and medical students learn greatly from these experts. In fact they may provide vital information to the students about the use of existing drugs and this will help them a lot in selecting their own P-drugs. Furthermore, authors' recommendation of use of a luminal amoebicide AFTER a course of nitroimidazole is contrary to the text book recommendation of its concurrent use.[45] Is a P-drug concept different from the principle of choosing a ‘drug’ of choice? The drug of choice for roundworm infestation is selected by using same criteria [Table 2].
Table 2

Criteria of selection of a suitable antihelminthic agent[3–4]

DrugEfficacySafetySuitabilityCost (Rs)
Albendazole400 mg single dose. Repeat after 3 days in heavy infectionsGenerally safe; may cause nausea abdominal distress, headache, lassitude.Oral route treats coexisting trichura, pin- worms, hook worms tablet, liquid8-12/tablet (chewable) maximum cost
Cure rate->90%Not safe in pregnancy20-24 per course
Pyrentel pamoate11 mg/kg-usually 1.0 G single doseMild abdominal distress, drowsiness, headache, insomnia, safety in pregnancy unknownOral single dose Tab=250 mg Liquid available18-20 per course
Cure rate-85-100%
Mebendazole100 mg twice a day for 3 daysGenerally safe mild GIT upset, allergyOral tab or liquid 100 mg tablet. Treats trichura, hookworm, pinworms also Tablet-500 mg liquid available7-16 per course
Cure rate-100%Not safe in pregnancy
Piperazine hexahydrate75 mg/kg usually 3.5-4.0 G /day for 2 daysGenerally mild headache, dizziness, neurotoxicity8.00-10.0 per course
Cure rate->90%Considered safe in pregnancy
Criteria of selection of a suitable antihelminthic agent[3-4] It is clear that albendazole is a drug of choice because of convenience of single dose, comparable efficacy, safety and cost. It can also be considered to be a P-drug for roundworm infestation.
  8 in total

1.  Assessment of Awareness among Clinicians about Concepts in Undergraduate Pharmacology Curriculum: A Novel Cross-sectional Study.

Authors:  R Mahajan; Nr Singh; J Singh; A Dixit; A Jain; A Gupta
Journal:  J Young Pharm       Date:  2010-07

2.  P-drug concept and the undergraduate teaching.

Authors:  Navyug Raj Singh
Journal:  Indian J Pharmacol       Date:  2008-11       Impact factor: 1.200

3.  Authors' reply.

Authors:  Gurudas Khilnani
Journal:  Indian J Pharmacol       Date:  2008-11       Impact factor: 1.200

4.  The concept of personal drugs in the undergraduate pharmacology practical curriculum.

Authors:  D M Parmar; S P Jadav
Journal:  Indian J Pharmacol       Date:  2008-11       Impact factor: 1.200

5.  Current scenario of attitude and knowledge of physicians about rational prescription: A novel cross-sectional study.

Authors:  Rajiv Mahajan; Navyug R Singh; Jaswinder Singh; Alok Dixit; Amit Jain; Ashwani Gupta
Journal:  J Pharm Bioallied Sci       Date:  2010-04

6.  Rational drug therapy education in clinical phase carried out by task-based learning.

Authors:  S Sırrı Bilge; Bahar Akyüz; Arzu Erdal Ağrı; Mıdık Özlem
Journal:  Indian J Pharmacol       Date:  2017 Jan-Feb       Impact factor: 1.200

7.  Implementation and assessment of a module to enhance prescribing competency in undergraduate medical students.

Authors:  Veena Nayak; Shalini Adiga; Smita Shenoy; Sadhana Holla
Journal:  Med J Armed Forces India       Date:  2021-02-02

8.  Medical Student Knowledge of Neglected Tropical Diseases in Peru: A Cross-Sectional Study.

Authors:  Renato A Errea; George Vasquez-Rios; Jorge D Machicado; Maria Susana Gallardo; Marilhia Cornejo; Jorge F Urquiaga; Diego Montoya; Rodrigo Zamudio; Angelica Terashima; Luis A Marcos; Frine Samalvides
Journal:  PLoS Negl Trop Dis       Date:  2015-11-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.